Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Cited By ~ 2

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

School Age ◽

Efficacy And Safety ◽

Once Daily ◽

Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder

Journal of Clinical Psychopharmacology ◽

10.1097/jcp.0000000000001222 ◽

2020 ◽

Vol 40 (4) ◽

pp. 350-358 ◽

Cited By ~ 1

Author(s):

Roberto Gomeni ◽

Marina Komolova ◽

Bev Incledon ◽

Stephen V. Faraone

Keyword(s):

Clinical Response ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder ◽

Model Based ◽

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

European Child & Adolescent Psychiatry ◽

10.1007/s00787-017-0962-6 ◽

2017 ◽

Vol 26 (8) ◽

pp. 875-897 ◽

Cited By ~ 13

Author(s):

Alain Joseph ◽

Rajeev Ayyagari ◽

Meng Xie ◽

Sean Cai ◽

Jipan Xie ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Mixed Treatment Comparison ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

Treatment Comparison ◽

Mixed Treatment

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.354 ◽

2017 ◽

Vol 56 (10) ◽

pp. S278-S279

Author(s):

Ann Childress ◽

Sally Berry ◽

Antonio Pardo ◽

Heidi W. Belden

Keyword(s):

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0044 ◽

2018 ◽

Vol 28 (1) ◽

pp. 10-18 ◽

Cited By ~ 10

Author(s):

Ann Childress ◽

Shailly Mehrotra ◽

Jogarao Gobburu ◽

Angus McLean ◽

Norberto J. DeSousa ◽

...

Keyword(s):

Single Dose ◽

Attention Deficit ◽

Extended Release ◽

Healthy Adults ◽

Hyperactivity Disorder ◽

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000220847.41027.5d ◽

2006 ◽

Vol 45 (7) ◽

pp. 817-823 ◽

Cited By ~ 41

Author(s):

LAURENCE L. GREENHILL ◽

RAFAEL MUNIZ ◽

ROBERTA R. BALL ◽

ALAN LEVINE ◽

LINDA PESTREICH ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2016.0177 ◽

2017 ◽

Vol 27 (8) ◽

pp. 690-699 ◽

Cited By ~ 7

Author(s):

Sharon B. Wigal ◽

Ann Childress ◽

Sally A. Berry ◽

Heidi Belden ◽

Faith Walters ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

Extended Release Tablet ◽

Release Tablet

Efficacy and Safety of Ritalin?? LA???, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

Pediatric Drugs ◽

10.2165/00148581-200305120-00006 ◽

2003 ◽

Vol 5 (12) ◽

pp. 833-841 ◽

Cited By ~ 64

Author(s):

Joseph Biederman ◽

Declan Quinn ◽

Margaret Weiss ◽

Sabri Markabi ◽

Meredith Weidenman ◽

...

Keyword(s):

Attention Deficit ◽

Dosage Form ◽

Extended Release ◽

Efficacy And Safety ◽

Once Daily ◽